Pibrentasvir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pibrentasvir, covering 2025-04-06 to 2025-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB) [Phase 3]